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Activities of Daily Living 
A B S T R A C T   
Introduction: : To date, mainly due to age-related vulnerability and to coexisting comorbidities, older patients 
often face a more severe COVID-19. This study aimed to identify at Emergency Department (ED) admission the 
predictors of in-hospital mortality and suitable scores for death risk stratification among COVID-19 patients ≥ 80 
years old. 
Methods: : Single-centre prospective study conducted in the ED of an university hospital, referral center for 
COVID-19 in central Italy. We included 239 consecutive patients ≥ 80 years old with laboratory-confirmed 
COVID-19. 
The primary study endpoint was all-cause in-hospital mortality. Multivariable Cox regression analysis was 
performed on significant variables at univariate analysis to identify independent risk factor for death. Overall 
performance in predicting mortality of WHO severity scale, APACHE II score, NEWS score, and CURB-65 was 
calculated. 
Results: : Median age was 85 [82-89] and 112 were males (46.9%). Globally, 77 patients (32.2%) deceased. The 
presence of consolidations at chest x-ray and the hypoxemic respiratory failure were significant predictors of 
poor prognosis. Moreover, age ≥ 85 years, dependency in activities of daily living (ADL), and dementia were risk 
factors for death, even after adjusting for clinical covariates and disease severity. All the evaluated scores showed 
a fairly good predictive value in identifying patients who could experience a worse outcome. 
Conclusions: : Among patients ≥ 80 years old hospitalized with COVID-19, not only a worse clinical and radio-
logical presentation of the disease, but also the increasing age, dementia, and impairment in ADL were strong risk 
factors for in-hospital death, regardless of disease severity.   
1. Introduction 
Since the first case identified in December 2019, the novel corona-
virus designated SARS-CoV-2, has determined the current tragic 
pandemic of respiratory illness named COVID-19.(W. Guan et al. 2020; 
Huang et al. 2020; Chen et al. 2020; Jin et al. 2020) Most countries in the 
world experienced an un-precedent pressure on health care systems, and 
the number of affected patients and death toll is still on the rise (WHO 
Coronavirus Disease (COVID-19) Dashboard, 2021). To date, despite the 
aggressive effort of containment, Italy has been facing one of the largest 
and most serious COVID-19 cluster, and the number of affected and 
deceased patients continue to increase (Livingston & Bucher, 2020; 
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Ministero della Salute, 2021). 
Older people, and those with comorbidities, are at higher risk of both 
severe infection (Wu & McGoogan, 2020) and death as a result of the 
disease (Gao et al. 2020; Zhou et al. 2020; Cheng et al. 2020) with a high 
fatality rate in patients aged 80 and above (Wu & McGoogan, 2020). 
Moreover, in older patients with COVID-19 emerged that not only the 
severity of COVID-19-related pneumonia or impairment of respiratory 
function, but also frailty and vulnerability are crucial determinant of 
poor prognosis (Lithander et al. 2020). However, routine medical 
assessment of COVID-19 patients seldom contemplated some of the key 
elements of risk in older persons, including dementia, or any degree of 
functional decline. 
Up to now, although several efforts have been expended to determine 
the severity and prognosis of COVID-19 cases (W. Guan et al. 2020; 
Huang et al. 2020; Chen et al. 2020; Livingston & Bucher 2020; Gao 
et al. 2020; Zhou et al. 2020; Cheng et al. 2020) risk stratification and 
identification of predictors for in-hospital mortality in acutely ill pa-
tients aged over 80 years remains a challenge. 
Thus, the aim of this study was to identify at ED admission the pre-
dictors of in-hospital mortality and suitable scores for death risk strati-
fication among COVID-19 patients ≥ 80 years. 
2. Methods 
2.1. Study design 
This is a single-centre, prospective observational study, conducted in 
the ED of an university hospital [Fondazione Policlinico A.Gemelli 
IRCCS, Rome], which is a referral centre for COVID-19, in central Italy. 
We evaluated all the patients ≥ 80 years, consecutively admitted to 
our ED with confirmed COVID-19 over a three-months period 
(September 1st to November 30th, 2020). COVID-19 was diagnosed on 
the basis of the WHO interim guidance. We included in the analysis only 
patients with positive result on real-time reverse-tran-
scriptase–polymerase-chain-reaction assay of nasal and pharyngeal 
swab specimens. 
We excluded patients already on orotracheal intubation at ED 
arrival, and patients for whom a do not resuscitate order was in place. 
2.2. Study variables 
The following information were evaluated:  
• Demographics: age, sex. 
• Clinical presentation at ED admission: fever, dyspnea, cough, diar-
rhea, headache, ageusia/anosmia, myalgia, confusion, syncope/pre- 
syncope.  
• Clinical history and comorbidities: hypertension, severe obesity 
(defined as BMI >40), history of coronary artery disease (CAD), 
congestive heart failure, cerebrovascular disease, dementia, dia-
betes, chronic obstructive pulmonary disease (COPD), chronic kid-
ney disease, malignancy. For each patient was also recorded if living 
in residential nursing facility and if had any impairment in activities 
of daily living (ADL) according to the Katz index of independence in 
activities of daily living (Katz et al. 1970). Overall comorbidity 
presence was assessed by Charlson Comorbidity index.  
• Physiological parameters at ED admission: body temperature, heart 
rate (HR), respiratory rate (RR), blood pressure (BP), Glasgow Coma 
Scale (GCS) peripheral oxygen saturation (SpO2).  
• Laboratory evaluation: For all patients we evaluated total white cell 
blood (WBC) count, lymphocyte count, lymphocyte to WBC ratio, 
blood glucose, creatinine, blood urea nitrogen (BUN), lactate dehy-
drogenase (LDH), sodium, potassium, C reactive protein (CRP), and 
serum lactic acid.  
• Blood gas evaluation: All patients had a blood gas evaluation at ED 
admission. Blood gas was obtained in room air when possible, and in 
case of severe respiratory distress at a FiO2 adequate for keeping 
peripheral oxygen saturation at least ≥ 90%. In cases needing 
ventilator support, first blood gas sample obtained before ventilation 
or soon after ventilation start was considered.  
• Radiological findings: defined as negative, interstitial involvement, 
and consolidative pneumonia.  
• Early warning scores: Different scores for patient evaluation and 
outcome prediction were calculated for patients in our cohort: World 
Health Organization (WHO) severity scale based solely on respira-
tory evaluation (SpO2, RR, presence of pneumonia); the National 
Early Warning Score (NEWS) severity score based on several physi-
ological parameters (HR, RR, BP, GCS, SpO2, Temperature) (Smith 
et al. 2013); the CURB-65 score for pneumonia severity (confusion, 
blood urea nitrogen, BP, RR, Age)(Lim, 2003); the Acute Physiologic 
Assessment and Chronic Health Evaluation (APACHE) II score (based 
upon initial values of 12 routine physiologic measurements, age, and 
previous health status)(Knaus et al. 1985) [Supplementary material, 
Table S1]. 
2.3. Study endpoints 
The end-point of the study was the all-cause in-hospital death. 
2.4. Statistical Analysis 
Continuous variables are reported as median [interquartile range], 
and are compared at univariate analysis by Mann-Whitney U test. Cat-
egorical variables are reported as absolute number (percentage), and are 
compared by Chi-square test (with Fisher’s test if appropriate). 
Receiver operating characteristic (ROC) curve analysis was used to 
evaluate the overall performance of the evaluated scores in predicting 
the defined adverse outcome. The comparison between the ROC AUCs 
was made according to DeLong method. 
Follow up and length of hospital stay were calculated from the time 
of ED admission to discharge or death. Evaluated parameters were 
assessed for association to all-cause in-hospital death by a univariate Cox 
regression analysis. Significant variables at univariate analysis were 
entered into a multivariate Cox regression model to identify indepen-
dent risk factor for survival. For a better model fitting and hazard esti-
mation, we categorized the continuous variables into dichotomous 
parameters (i.e. low/high). For each variable, we obtained the optimal 
dividing cut-off by Youden’s index, performing a ROC curve analysis 
with respect to association with death. To avoid model redundancy or 
overfitting, some variables were excluded from the analysis, since they 
were derived (like Charlson Index, early warning scores, lymphocyte/ 
WBC ratio). Similarly, for blood gas sample we considered PaO2/FiO2, 
and excluded from multivariate model PaO2 and FiO2 as single items. 
Survival curves were estimated by the Kaplan-Meier methods. Associa-
tion of factors to risk of intra hospital death is expressed as Hazard Ratio 
(HR) [95% confidence interval]. We considered significant a two-sided p 
≤ 0.05. Data were analyzed by SPSS v25® (IBM, Armonk NY, USA). 
2.5. Statement of ethics 
The study was conducted in accordance with the Declaration of 
Helsinki and approved by the Local Ethical Committee. All patients gave 
their informed consent to collect clinical and laboratory data. 
3. Results 
Overall, 239 patients aged between 80 and 100 years met the in-
clusion criteria and were included in the study cohort. Thirteen patients 
(5.4%) were transferred to residential COVID facility for quarantine. 
Twelve patients (5.0%) were discharged home from ED. 
Globally, 77 patients (32.2%) deceased. Four patients (1.7%) died in 
ED prior than ward admission. Median time from ED admission to death 
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was 9.9 [3.5 – 15.4] days. 
3.1. Demographic, ED presentation and clinical history 
Median age was 85[82-89], 112 were males (46.9%). Figure 1 de-
scribes age distribution in our cohort. Most of patients reported fever 
(82.8%), dyspnea (59.0%), and cough (45.1%) as main symptoms. 
Interestingly, anosmia/ageusia were reported only by few subjects 
(1.3%) (Table 1). 
Most of patients admitted to ED had some alteration of physiological 
parameters. However, a significant difference between deceased and 
survived patients emerged only for peripheral oxygen saturation at 
admission (Table 1). 
Not surprisingly, most of the enrolled patients (63.9%) had impair-
ment in ADL, and about half of them lived in a residential nursing fa-
cility. Major comorbidities included hypertension (40.2%), dementia 
(16.7%), diabetes (14.6%), and congestive heart failure (10%). Median 
Charlson comorbidity index was 4 [4 – 5] (Table 1). 
Deceased patients were significantly older and had higher Charlson 
comorbidity index. Living in institution and being dependent in ADL was 
significantly associated to poor prognosis. Among comorbidities 
considered in Charlson comorbidity score, dementia, cerebrovascular 
disease and congestive heart failure were significantly associated to 
death at univariate analysis (Table 1). 
3.2. Laboratory findings 
Considering laboratory values, many were associated with poor 
prognosis at univariate analysis. In particular, deceased patients showed 
a higher WBC count, lower lymphocyte count and lower lymphocyte/ 
WBC ratio. Moreover, a significantly higher BUN, blood glucose, LDH, 
CRP, and lactic acid, were associated to death in our cohort (Table 1). 
3.3. Blood gas evaluation 
Higher need of oxygen supplement was associated to worse prog-
nosis (Table 1). Similarly, a lower PaO2, PaO2/FiO2 ratio, and HCO3- 
were associated to death in our cohort. 
3.4. Radiological findings 
Most of the enrolled patients (>80 %) had the pulmonary 
involvement of the disease, as confirmed by chest x-ray findings. A more 
severe pulmonary involvement at chest x-ray was associated to a sig-
nificant worse prognosis (Table 1). 
3.5. Risk Scores evaluation 
All the four scoring system evaluated in our cohort showed a fair 
predicting ability for death prediction. The WHO severity scale had a 
slightly higher ROC AUC among them, although it was not significantly 
different from APACHE II score, NEWS score, and CURB-65 index 
(Table 2). However, while NEWS, WHO scale, and APACHE performed 
pretty similar, CURB-65 showed a slightly lower ROC AUC. 
3.6. Multivariate analysis 
When entered into a multivariate COX regression model, several 
factors emerged as independent risk factors for death. Among de-
mographic factors, increasing age played a significant role, being death 
hazard ratio more than doubled for age ≥ 85 years (Table 3). Among the 
clinical history covariates, dependency in ADL, dementia, and conges-
tive heart failure were the strongest risk factor for death with respec-
tively 2.57, 2.37, and 2.09 hazard ratios, respectively (Table 3). 
As expected, chest x-ray findings were significantly associated to 
increased death risk, and patients with pulmonary consolidation had 
almost fourfold risk of death, when compared to negative chest x-ray. 
Patients with interstitial involvement showed a tendency toward a 
hazard risk increase, although not reaching statistical significance 
(Table 3). 
Among the laboratory values evaluated a higher CRP, LDH, and 
lactic acid were independent risk factors for death. As expected, a lower 
PaO2/FiO2 at admission was a significant risk factor for poor prognosis. 
4. Discussion 
The main finding of this study is that among patients ≥ 80 years old 
hospitalized with COVID-19, in addition to worse clinical and radio-
logical presentation of the disease, also the increasing age, dementia, 
and impairment in ADL were strong risk factors for all cause in-hospital 
death, even after adjusting for clinical covariates and disease severity. 
Moreover, in this population the WHO severity scale, APACHE II score, 
NEWS score, and CURB-65 showed a fairly good predictive value in 
identifying at ED admission patients who could experience a worse 
Figure 1. Age distribution of the enrolled patients. Dividing our patients in 5 year age groups, death ratio is 19% in 80-84 years old, 38% in 85-89 years old, 41.5% 
in 90-94 years old, 71.4% in ≥ 95 years old (p<0.001) 
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outcome. 
COVID-19 pandemic is posing an outstanding challenge on health 
care systems worldwide, and the number of affected patients and deaths 
is still on the rise. Older people, and those with comorbidities, are at 
greater risk of requiring hospitalization or dying if they are diagnosed 
with COVID-19(Wu & McGoogan, 2020; Becerra-Muñoz et al. 2020). 
Indeed, in older patients with COVID-19 emerged that not only the 
severity of COVID-19-related pneumonia or impairment of respiratory 
function, but also frailty and vulnerability are crucial determinant of 
poor prognosis (Aliberti et al. 2021; Hwang et al. 2020). Consequently, 
mainly due to age-related vulnerability and to the several complications, 
the older patients are facing a more severe COVID-19. 
This study was focused on a cohort of older patients with COVID-19 
aged ≥80 years old. To the best of our knowledge, the proportion of 
these patients in the current study is one of the largest analysed to date. 
Thus far, clear evidence exists about the role of age as a risk factor of 
death in patients with COVID-19(W. Guan et al. 2020; Huang et al. 2020; 
Chen et al. 2020; Jin et al. 2020; WHO Coronavirus Disease (COVID-19) 
Dashboard 2021; Livingston & Bucher 2020; Ministero della Salute 
2021). However, most of reported data included only few hospitalized 
patients older than 80 or 85 years. In this study we confirmed that even 
considering only patients older than 80 years, the increasing age was by 
itself an independent risk factor for death. In our cohort, dividing our 
patients for 5-year group, death ratio ranged from 19% in 80-84 years 
old, to 71.4% in ≥ 95 years old (Figure 1). It is arguable that the overall 
reduced physical fitness associated to older age could play a significant 
Table 1 
Demographic and clinical characteristics of enrolled patients at ED admission  







Age 85 (82 – 89) 84 (82 – 88) 87 (84 – 92) <0.001 
Sex (male) 112 (46.9%) 74 (45.7%) 38 (49.7%) 0.595 
Clinical presentation 
Fever 198 (82.8%) 137 (84.6%) 61 (79.2%) 0.306 
Dyspnea 141 (59.0%) 94 (58.0%) 47 (61.0%) 0.658 
Cough 102 (45.1%) 73 (45.1%) 29 (37.7%) 0.280 
Diarrhea 10 (4.2%) 9 (5.6%) 1 (1.3%) 0.174 
Headache 15 (6.3%) 8 (4.9%) 7 (9.1%) 0.216 
Ageusia/anosmia 3 (1.3%) 1 (0.6%) 2 (2.6%) 0.244 
Myalgia 17 (7.1%) 15 (9.3%) 2 (2.6%) 0.103 
Confusion 11 (4.6%) 8 (4.9%) 3 (3.9%) 0.977 
Syncope/pre-syncope 10 (4.2%) 7 (4.3%) 3 (3.9%) 0.878 
Physiological parameters 
Heart Rate (beats/ 
min) 
85 (82 – 89) 84 (82 – 88) 87 (84 – 92) 0.678 
SpO2 (%) in ambient 
air 
94 (90 – 97) 94 (91 – 97) 93 (87 – 96) 0.037 
Respiratory rate 
(breaths/min) 
25 (21 – 28) 24 (20 – 28) 26 (22 – 28) 0.124 
SBP (mmHg) 128 (115 – 
140) 
129 (120 – 
141) 
124 (110 – 
140) 
0.075 
DBP (mmHg) 76 (66 – 84) 77 (69 – 85) 70 (60 – 81) 0.110 
MBP (mmHg) 93 (84 – 
102) 
95 (86 – 103) 90 (80 – 100) 0.021 
GCS 15 (14 – 15) 15 (14 – 15) 15 (14 – 15) 0.762 
Body Temperature 
(◦C) 
36.0 (36.0 – 
37.2) 
36.5 (36 – 
37.3) 
36.5 (36.0 – 
37.0) 
0.730 
Clinical history and comorbidities 
Charlson comorbidity 
index 
4 (4 – 5) 4 (4 – 5) 5 (4 – 6) 0.007 
Dependent in ADL 145 (63.9%) 82 (53.9%) 63 (84.0%) <0.001 
Living in institution 117 (49.0%) 68 (42.0%) 49 (63.6%) 0.002 
Hypertension 96 (40.2%) 64 (39.5%) 32 (41.6%) 0.762 
Dislipidemia 16 (6.7%) 13 (8.0%) 3 (3.9%) 0.233 
Severe obesity 2 (0.8%) 1 (0.6%) 1 (1.3%) 0.541 
History of CAD 18 (7.5%) 10 (6.2%) 8 (10.4%) 0.248 
Congestive heart 
failure 
24 (10.0%) 10 (6.2%) 14 (18.2%) 0.004 
Cerebrovascular 
disease 
12 (5.0%) 5 (3.2%) 7 (9.1%) 0.047 
Dementia 40 (16.7%) 21 (13.0%) 19 (24.7%) 0.023 
COPD 32 (13.4%) 22 (13.6%) 10 (13.0%) 0.900 
Diabetes 35 (14.6%) 23 (14.2%) 12 (15.6%) 0.777 
Chronic kidney 
disease 
10 (4.2%) 7 (4.3%) 3 (3.9%) 0.878 
Malignancy 5 (2.1%) 1 (0.6%) 4 (5.2%) 0.038 
Laboratory evaluation 











990 (710 – 
1340) 
1020 (757 – 
1370) 





0.14 (0.08 – 
0.23) 
0.17 (0.11 – 
0.24) 
0.11 (0.06 – 
0.19) 
<0.001 
Blood glucose (mg/ 
dL) 
109 (91 – 
138) 
104 (89 – 
129) 
122 (99 – 
172) 
0.002 
Creatinine (mg/dL) 1.01 (0.76 – 
1.46) 
0.97 (0.71 – 
1.38) 
1.13 (0.79 – 
1.83) 
0.104 
BUN (mg/dL) 24 (18 – 37) 22 (16 – 30) 31 (23 – 46) <0.001 
LDH (UI/L) 280 (200 – 
379) 
267 (198 – 
373) 
295 (225 – 
503) 
0.023 
Sodium (mEq/L) 136 (129 – 
141) 
137 (130 – 
140) 
134 (127 – 
138) 
0.378 
Potassium (mEq/L) 4.1 (3.8 – 
4.5) 
4.1 (3.9 – 
4.4) 
4.3 (3.9 – 
4.6) 
0.435 
CRP (mg/L) 65 (27 – 
133) 





1.2 (0.8 – 
1.8) 
1.1 (0.8 – 
1.5) 
1.4 (1.1 – 
2.2) 
<0.001 
Blood gas evaluation 
FiO2 (%) 24 (21 – 31) 21 (21 – 27) 28 (21 – 40) <0.001 
pH 7.45 (7.41 – 
7.48) 
7.45 (7.40 – 
7.48) 
7.45 (7.41 – 
7.50) 
0.304 
PaO2 (mmHg) 66 (57 – 80) 67 (60 – 82) 63 (52 – 76) 0.037  
Table 1 (continued ) 







PaCO2 (mmHg) 35 (31 – 40) 35 (31 – 39) 35 (30 – 39) 0.480 
HCO3- (mmol/L) 26 (23 – 28) 26 (24 – 28) 25 (22 – 27) 0.015 
PaO2/FiO2 276 (214 – 
333) 
297 (229 – 
345) 




Negative 40 (16.7%) 35 (21.6%) 5 (6.5%)  
Interstitial 
involvement 
98 (41.0%) 76 (49.9%) 22 (28.6%) <0.001 
Consolidation 101 (42.3%) 51 (31.5%) 50 (64.9%)  
Abbreviations: SpO2, peripheral oxygen saturation; SBP, systolic blood pressure; 
DBP, diastolic blood pressure; MBP, mean blood pressure; GCS, Glasgow Coma 
Scale; ADL, Activities of daily living; CAD, Coronary artery disease; COPD 
Chronic Obstructive Pulmonary Disease; WBC, white blood cells; BUN, blood 
urea nitrogen; LDH, lactate dehydrogenase; CRP, C reactive protein; FiO2, 
fraction of inspired oxygen; PaO2, partial pressure of oxygen; PaCO2, partial 
pressure of carbon dioxide 
Table 2 
Sensitivities, specificities, negative and positive predictive values, positive and 
negative likelihood ratios for WHO severity scale, NEWS, CURB-65 and APACHE 
scoring systems for predicting death of COVID-19 patients ≥80 years old.  






≥ 2 75 (64 – 
84) 











≥ 5 69 (57 – 
79) 











≥ 5 32 (22 – 
44) 













≥ 26 62 (51 – 
73) 








Abbreviations: WHO, World health organization; NEWS, National early warning 
score; APACHE II, Acute Physiologic Assessment and Chronic Health Evaluation 
II 
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role for death risk. Similarly, other conditions that reduce overall 
physical fitness, as expressed by impairment in ADL and low Barthel 
index, were already found to be associated to an increased hazard for 
death in COVID-19 patients (Laosa et al. 2020; Heras et al. 2020). 
Nevertheless, no final clues are available to explain why COVID-19 is 
disproportionately killing older people(Mueller, McNamara, & Sinclair 
2020; Blagosklonny, 2020). 
Our data also confirmed the negative impact of dementia on COVID- 
19 prognosis (Covino, De Matteis, et al. 2020) showing in our cohort an 
adjusted hazard risk of death in patients with dementia of 2.34. Simi-
larly, in a recent meta-analysis on 56577 patients with COVID-19, de-
mentia whose prevalence was about 10%, was associated with increased 
mortality in both pooled unadjusted and adjusted effect estimates, with 
about a two-fold risk of death (Hariyanto et al. 2021). 
Likewise, a post-hoc analysis of the international, multicentre, ‘real- 
world’ HOPE COVID-19 registry on patients aged ≥65 years hospitalized 
for COVID-19, also including a group of 585 patients aged ≥80 years old, 
showed as dementia was an independent predictor of mortality in this 
population (Foley, Affoo, & Martin 2015). Although the link between 
dementia and death could not appear obvious for COVID-19 older pa-
tients, it is well known that the risk of pneumonia-associated mortality is 
significantly increased in patients with any form of cognitive impair-
ment(Numbers & Brodaty 2021) . Moreover, a latest report describing 
the effects of the COVID-19 pandemic on people suffering dementia 
reported that these patients have a relatively high risk both of con-
tracting severe disease and of neuropsychiatric disturbances and 
delirium, also as a result of lockdown measures and social isolation 
(Garcez et al. 2020). In addition, delirium itself has been reported to be 
an independent predictor for death in COVID-19 patients (Garcez et al. 
2020). 
These findings confirmed that special support is needed for older 
COVID-19 patients with impaired physical and cognitive function. First 
and foremost, these patients should be given extra care and prevention 
to minimize exposure to the virus guaranteeing both strategies of 
monitoring and quick access to healthcare, also by implementing tele-
medicine and virtual consultations. Second, hospitals should be equip-
ped of COVID-19 geriatric care units with a multidisciplinary team of 
mental health professionals (doctors, nurses and psychologists), to 
provide a careful and comprehensive evaluation, and better care for 
these patients (Hariyanto, Putri, et al 2020). Lastly, also caregivers 
should be involved in close monitoring of COVID-19 older patients, 
promoting better medications adherence (Hariyanto & Kurniawan, 
2020a) and contributing to a multi-component program including psy-
chological strategies, lifestyle changes, nutrition habits, and cognitive 
stimulation exercises, aiming to reduce disease severity and mortality by 
preventing social isolation, physical and mental inactivity. Hence, these 
strategies could help to improve health status in older COVID-19 pa-
tients, particularly in those with frailty, associated comorbid conditions 
(Hariyanto & Kurniawan, 2020b) and dementia. 
Moreover, not surprisingly, in our cohort of COVID-19 patients aged 
80 years or more we found that several factors depicting a severe disease 
at ED admission were associated to an increased risk of poor outcome, as 
previously described both in younger populations and in those of similar 
age (Zhou et al. 2020). As expected, since in COVID-19 patients the 
acute hypoxia is the main determinant of disease progression and 
severity, the blood gas evaluation provides significant information and 
has a relevant role in risk prediction for death at ED admission. Our data 
confirmed that among the blood gas parameters the PaO2/FiO2 is the 
best predictor even after adjusting for other covariates, and that also in 
patients who are 80 years of age or older, hypoxia is the main deter-
minant of disease severity (Grasselli et al. 2020). 
Among laboratory values, we found that both an elevated LDH, CRP, 
and serum lactic acid were independent risk factors for death. An 
elevation of LDH in COVID-19 deceased patients was found in several 
studies(Zhou et al. 2020; X. Guan et al. 2021; Lv et al. 2020). These 
findings appear to be consistent with a previous report on the predictors 
of disease severity in SARS infection, where multivariate analysis 
identified elevated LDH as a marker associated with worse outcomes 
(Leong et al. 2006). Indeed, lactate dehydrogenase is a non-specific 
marker, and it is usually increased in critically ill patients. Similarly, 
serum lactic acid levels represent both a marker of illness severity and a 
therapeutic target, and the higher is the level, the greater is the risk of 
death. Hyperlactatemia usually occurs in inadequate tissue perfusion 
and oxygenation, and is common in Sars-CoV-2 infection, since hypoxia 
is the mainstay of severe COVID-19, also in older COVID-19 patients 
(Foucher & Tubben, 2020; Bahl et al. 2020). C-reactive protein level 
correlates to inflammation and its concentration is not affected by age, 
sex, and physical condition (Chalmers et al. 2019). CRP is also a 
well-known index of severe pulmonary infections, and CRP levels were 
found to positively correlate with disease severity in COVID-19 (X. Guan 
et al. 2021; Huang et al. 2020; Chen et al. 2020; Jin et al. 2020; WHO 
Coronavirus Disease (COVID-19) Dashboard 2021; Covino, De Matteis, 
et al. 2020; Chalmers et al. 2019; Wang 2020). These results confirmed 
that an elevated CRP could have a predictive role in patients ≥ 80 years 
with COVID-19 (Covino, De Matteis, et al. 2020). 
In addition, also in our cohort of older COVID-19 patients we 
strengthened the role of the worse clinical findings at chest x-ray as 
independent risk factor for a poor prognosis. Interestingly, after 
adjusting for other covariates, only the presence of consolidation was an 
independent predictor of death, whereas the interstitial involvement 
alone did not reach statistical significance. Although limited by the 
relatively small study cohort, our results are similar to those reported by 
several studies showing that the outcome in COVID-19 could be pre-
dicted by the radiological estimation of the residual ventilated lung area 
(Colombi et al. 2020). 
Several early warning score have been evaluated and proposed for 
death risk prediction in COVID-19 both in general population (Covino, 
Sandroni, et al. 2020; Liang et al. 2020; Haimovich et al. 2020; Knight 
et al. 2020), and in older patients (Covino, De Matteis, Burzo, Russo, 
Table 3 
Multivariate Cox regression model for survival.   
β Standard 
Error 
Hazard ratio (95% 
CI) Adjusted model 
P- 
value 
Age ≥ 85 0.876 0.303 2.40 [1.32 – 4.35] 0.004 
Dependency in ADL 0.945 0.416 2.57 [1.14 – 5.82] 0.023 
Resident in nursing 
facility 
-0.187 0.329 0.83 [0.44 – 1.58] 0.570 
Dementia 0.852 0.288 2.34 [1.33 – 4.12] 0.003 
Cerebrovascular 
disease 
0.067 0.486 1.07 [0.41 – 2.77] 0.891 
Congestive heart 
failure 
0.661 0.306 1.94 [1.06 – 3.53] 0.031 
Chest X ray findings 
• Negative   Reference 0.047 
• Interstitial 
involvement 
0.955 0.552 2.59 [0.88 – 7.67] 0.084 
• Consolidation 1.300 0.551 3.67 [1.24 – 10.81] 0.018 
WBC > 8860 (cells/ 
mm3) 
0.280 0.271 1.32 [0.78 – 2.25] 0.302 
Lymphocyte ≤ 790 
(cells/mm3) 
0.437 0.253 1.55 [0.94 – 2.54] 0.085 
Blood glucose > 101 
(mg/dL) 
0.461 0.272 1.58 [0.93 – 2.70] 0.091 
BUN > 20 (mg/dL) 0.306 0.382 1.36 [0.64 – 2.88] 0.424 
LDH > 489 (UI/L) 0.731 0.286 2.08 [1.19 – 3.64] 0.011 
CRP > 121 (mg/L) 0.876 0.279 2.40 [1.39 – 4.15] 0.002 
Serum Lactate > 1.5 
(mmol/L) 
0.508 0.251 1.66 [1.02 – 2.72] 0.043 
SpO2 < 88% in 
ambient air 
0.354 0.314 1.42 [0.77 – 2.63] 0.261 
PaO2/FiO2 < 261 0.516 0.347 1.67 [1.03 – 2.72] 0.037 
Abbreviations: ADL, Activities of daily living; WBC, white blood cells; BUN, 
blood urea nitrogen; LDH, lactate dehydrogenase; CRP, C reactive protein; SpO2, 
peripheral oxygen saturation; FiO2, fraction of inspired oxygen; PaO2, partial 
pressure of oxygen 
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et al. 2021). The WHO severity scale performs similar to other EWS in 
older adults, and could be evaluated without laboratory and radiological 
findings (Covino, De Matteis, Burzo, Franceschi, et al. 2021). At the 
same time, if already in use in the ED, the NEWS score performs fairly for 
COVID-19 patients (Covino, Sandroni, et al. 2020), and there is probably 
no meaning in the use of complicate calculation such as for APACHE II. 
CURB-65 could be used for risk stratification of COVID-19 patients 
(Bradley et al. 2020). However, since not every patient has pneumonia, 
we do not support the use of this latter score for all COVID-19. Present 
data, and previously published studies (Covino, Sandroni, et al. 2020; 
Liang et al. 2020; Haimovich et al. 2020; Knight et al. 2020; Covino, De 
Matteis, Burzo, Russo, et al. 2021; Covino, De Matteis, Burzo, France-
schi, et al. 2021) confirm that in older adults no EWS is really superior to 
others, and clinical implementation should be driven by simplicity in 
calculation and pre-existent local protocols. Hence, all the severity 
scores including a respiratory function evaluation showed a fairly good 
predictive value in identifying patients who could experience a worse 
outcome, also in this cohort of older patients. 
Our study presents several limitations. Firstly, our sample is limited. 
Secondly, this study was conducted in a single institution which is a 
referral COVID-19 centre and therefore our result could not be gener-
alizable. Thirdly, some important severity markers as D-Dimer and al-
bumin, that a latest report suggested to use for predicting severe 
outcomes in COVID-19, were not included in this study (Hariyanto, 
Japar, Kwenandar et al. 2021). Finally, we included in our series only 
patients confirmed Sars-CoV2 positive at nasal and pharyngeal swab 
specimens. Indeed, while this could help to provide robust data on 
COVID-19, it excluded several patients with suggestive symptoms and 
radiological findings from our analysis. 
5. Conclusions 
Among patients ≥ 80 years old hospitalized with COVID-19, not 
barely the worse clinical and radiological presentation of the disease, 
but also the increasing age, dementia, and impairment in ADL were 
strong risk factors for all cause in-hospital death, regardless of disease 
severity. As expected, also in this population the severity scores 
including a respiratory function assessment, as well as WHO severity 
scale, APACHE II score, NEWS score, and CURB-65, showed a fairly good 
predictive value in identifying at ED admission patients who could 
experience a poor outcome. 
These findings confirmed that special support is needed for older 
patients with impaired physical and cognitive function. Accordingly, 
caregivers and physicians should be aware of the peculiar characteristics 
of COVID-19 in patients aged ≥80 years old. 
Sources of Funding 
This research did not receive any specific grant from funding 
agencies in the public, commercial, or not-for-profit sectors. 
CRediT authorship contribution statement 
Marcello Covino: Conceptualization, Methodology, Software, Data 
curtion, Formal analysis, Writing - review & editing. Giuseppe De 
Matteis: Conceptualization, Validation, Visualization, Writing - original 
draft, Writing - review & editing. Davide Antonio Della Polla: Vali-
dation, Visualization, Writing - original draft, Writing - review & edit-
ing. Michele Santoro: Software, Formal analysis. Maria Livia Burzo: 
Validation, Visualization, Writing - original draft, Writing - review & 
editing. Enrico Torelli: Software, Formal analysis. Benedetta Simeoni: 
Writing - review & editing. Andrea Russo: Writing - review & editing. 
Claudio Sandroni: Conceptualization, Methodology, Writing - review 
& editing. Antonio Gasbarrini: Conceptualization, Methodology, 
Writing – review & editing. Francesco Franceschi: Conceptualization, 
Methodology, Data curtion, Writing - review & editing, Supervision. 
Declaration of Competing Interest 
The authors have no financial or other personal conflict with this 
paper. 
Supplementary materials 
Supplementary material associated with this article can be found, in 
the online version, at doi:10.1016/j.archger.2021.104383. 
References 
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